Troy Anthony Appleton

Troy Anthony Appleton is an accomplished inventor based in East Lyme, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative solutions to improve patient care, particularly in the area of chemotherapy.

Latest Patents

Appleton's latest patents include the development of polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions. This invention features two crystalline polymorphic forms, known as Form I and Form II, which are designed to enhance the stability of formulations aimed at treating emesis in patients undergoing chemotherapy. The pharmaceutical composition can be administered orally, preferably in tablet or capsule form, or intravenously. Additionally, he has developed a hemiphosphate hemihydrate salt of 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole, which serves as a preferred salt for an antiulcer agent.

Career Highlights

Troy Appleton is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other talented professionals in the industry, contributing to the advancement of medical science.

Collaborations

Some of his notable coworkers include Douglas J M Allen and Michael Jon Gumkowski. Their combined expertise fosters a collaborative environment that drives innovation and enhances the development of new pharmaceutical solutions.

Conclusion

Troy Anthony Appleton's contributions to the field of pharmaceuticals exemplify the impact of innovation on patient care. His patents reflect a commitment to improving treatment options for patients, particularly those facing the challenges of chemotherapy.